ADO

8.70%

2.1¢ anteotech ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-83

First 83 Last

Share
Profile

Follow
Trevor Gripper

1,560 Posts.

182

31/01/24

10:39

Post #: 72152828
Share

Originally posted by captainblood: ↑

jandb has given us an overview of where revenue could and most likely will be coming from our life science division. here is mine of our CET.

we had an announcement on dec 7th that we had delivered a high silicon anode to ev1. allowing them some time to manufacture the completed battery and to start testing, I have their testing being around 200+ cycles. (55 days at 6 cycles/day, less set up time) by the end of feb should be around 400. at this stage they will be able to compare anteotech's 1/2 cell and coin cell results and most likely some initial testing they have done. I don't expect the 1st testing they have done is with a full battery cell. how far away will a deal be? maybe not the main deal we are waiting for but one to more formal agreement

then we have been told that we have successfully produced our own ultra high silicon anode containing 70% silicon. how many of our partners will be wanting to get their hands on that? not sure we are giving this out without a formal agreement being signed.

from the agm presentation we have been given the names of the partners closer to commercial deals and again in this 4c ( I see the 1st time they have named a giga battery manufacturer in an ann, ACC anyone)

"This includes two major electric vehicle manufacturers, a bespoke battery manufacturer and a giga battery manufacturer, a global specialised chemical company, along with existing partners, Trinseo and Wyon."

then we had

"Another key takeaway was that potential customers are willing to pay for access to AnteoTech’s highly skilled technical team and tailored test samples, prior to engaging in a long-term supply agreement."

"While our soon to be completed Brisbane facility will be hugely beneficial to enable initial supplies of Anteo X and early commercial production runs,"

when the production facility is up and producing shortly, more revenue will be flowing our way. this is something shareholders having being crying out for, for years. not just being a non for profit research arm of these collaborators

then from the dec battery conference

"The conference also provided an opportunity to engage with a number of new potential customers, with delegates representing a variety of specialised battery companies including both the giga factories and major international EV companies."

will they need anteoX for testing?

shortly we will have multiple companies doing production run tests on anteox and our high silicon anodes, with ado receiving revenue from all of them. I also imagine Anteotech management will be wanting some more formal agreements with these companies or we will get ourselves into a ferro type situation again. ev1 has got 1st in advantage of skipping this.

get the production facility producing, get gov't non dilutionary funding to further scale it up to 80k litres capacity and the revenue will start to trickle in which will hopefully later become substantial.

it's all starting to get closer and closer. tomorrow is early February. let the announcements start to roll out......

Expand

Jason and Belinda also gave many rundowns on where the revenue from Covid testing was going to come from and how years in the future there was going to be millions of Anteo tests being sold with wave after wave of Covid coming down upon us and he was so far off the mark that Belinda is still trying to get him to remove her name of their cute handle

ADO Price at posting: 3.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 64 more messages in this thread...

First 83 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change -0.002(8.70%)		Mkt cap ! $52.28M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.1¢	$20.83K	964.6K

Buyers (Bids)

No.	Vol.	Price($)
4	2247357	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	164375	3

View Market Depth

No.	Vol.	Price($)
2	739397	0.021
9	1445497	0.020
10	2127381	0.019
4	1601447	0.018
3	1564748	0.017

Price($)	Vol.	No.
0.023	642868	9
0.024	741966	3
0.025	478846	7
0.026	83915	2
0.027	250000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

ADO (ASX) Chart

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-83

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-83

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News